Chargement en cours...
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
Spasticity, one of the main symptoms of multiple sclerosis (MS), can affect more than 80% of MS patients during the course of their disease and is often not treated adequately. δ-9-Tetrahydrocannabinol-cannabidiol (THC-CBD) oromucosal spray is a plant-derived, standardized cannabinoid-based oromucos...
Enregistré dans:
| Publié dans: | Ther Adv Neurol Disord |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4710104/ https://ncbi.nlm.nih.gov/pubmed/26788128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285615612659 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|